Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology
Icosavax creates virus-like particles using technology licensed from the University of Washington’s Institute for Protein Design. (Icosavax photo) New financing: At a moment when everyone is talking about vaccines, a …